The global radiopharmaceuticals market is expected to reach a value of USD 10,473.88 million by 2023 due to rising applications of nuclear medicine. The growth is facilitated by domestic production of radioisotopes and efforts taken by countries to encourage the growth of diagnostic imaging. Drug approvals















